Walking program eased chemo-related joint pain
11/26/13
SAN DIEGO – A 6-week, low-impact walking
program relieved joint pain and stiffness and increased the number of
minutes per week walking among elderly breast cancer survivors on
aromatase inhibitors.
"A breast cancer diagnosis can be an ‘a-ha’ moment
for women," Kirsten A. Nyrop, Ph.D, said during a press briefing at the
annual meeting of the American College of Rheumatology. "Some of the
women with whom we spoke said: ‘My cardiologist told me to walk and my
general practitioner told me to walk, but when my oncologist asked me to
walk, I started walking.’ "
Doug Brunk/IMNG Medical Media
Kirsten A. Nyrop, Ph.D. |
Dr.
Nyrop, of the Thurston Arthritis Research Center at the University of
North Carolina at Chapel Hill, and her associates studied 20 patients
who were taking an aromatase inhibitor for stage I-III breast cancer and
had self-reported joint pain. The walking program they used was the
Arthritis Foundation’s Walk With Ease. The program recommends that participants walk 30 minutes per day at least 5 days per week.
"We wanted to be certain we were reaching these
women with a message that would resonate with them and a program that
they felt was safe, something that they could comfortably do," Dr. Nyrop
said.
The researchers administered visual analog scales
(VAS) for joint pain, stiffness, and fatigue, as well as Arthritic
Self-Efficacy (ASE) scales for joint and pain symptoms. The mean age of
study participants was 71 years, 85% were white, and their mean body
mass index was 29 kg/m2.
After 6 weeks in the walking program, researchers
noticed improvements from baseline in the VAS pain score (effect size =
0.15) and VAS fatigue score (effect size = 0.22); changes in the VAS
stiffness score approached statistical significance (effect size =
0.56). "That’s promising," Dr. Nyrop said. Scores on the ASE scales also
improved from baseline for pain and fatigue, but the changes did not
reach significance.
Significant increases in walking were observed from
baseline in terms of the number of times per week walked (mean increase
of 1.9 times; effect size = 0.68), number of minutes per walk (mean
increase of 8.3 minutes; effect size = 0.48), and total number of
minutes walked per week (mean increase of 62.6 minutes; effect size =
0.53).
One study participant wrote: "I absolutely feel the
connection between aromatase inhibitors and exercise. On days I don’t
walk, I am stiff, but if I walk, I am not stiff. Keep moving; it really
helps."
A larger, follow-up study with a randomized controlled design is underway with funding by the National Cancer Institute.
The study was funded by the University of North
Carolina Institute on Aging. Dr. Nyrop said that she had no relevant
financial conflicts to disclose.
Copyright © 2013 International Medical News Group, LLC. All rights reserved.
This page was printed from www.familypracticenews.com . For reprint inquires, call 877-652-5295, ext. 102.
Comments
Post a Comment